Generic Kaftrio 75mg/50mg/100mg tablets
NHS hospitals in England used £519,411,711 of indicative cost of Generic Kaftrio 75mg/50mg/100mg tablets in the 12 months to April 2026, about 2.0% of all hospital medicines spend. That is down 7.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Generic Kaftrio 75mg/50mg/100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Generic Kaftrio 75mg/50mg/100mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £55,193,486 |
| Manchester University Nhs Ft | £51,828,585 |
| Leeds Teaching Hpls Nhs Trust | £35,100,365 |
| Royal Papworth Hospital Nhs Ft | £32,158,294 |
| Liverpool Heart & Chest Hosp Found Trust | £28,736,311 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £27,150,514 |
| Univ Hpls Bristol Nhs Foundation Trust | £25,752,509 |
| Nottingham University Hospitals Trust | £25,256,798 |
| University Hospital Southampton Nhs Ft | £25,130,709 |
| King's College Hpl Nhs Foundation Trust | £22,507,586 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.